Homeobox B13 activates the hypoxia‐inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma
Qingqing Xie, Fangxia Teng, Ting Ding, Huaizhe Zhang, Jian Huang, Shu Zhang · 2026
Read Homeobox B13 activates the hypoxia‐inducible factor 1 pathway through histone lactylation thereby reprogramming lipid metabolism and promoting sorafenib resistance in hepatocellular carcinoma by Qingqing Xie, Fangxia Teng, Ting Ding, Huaizhe Zhang, Jian Huang, Shu Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13148139.txt.
Description
Liver cancer often learns to shrug off a front-line drug, and fat rewiring helps it hide. Qingqing Xie and co-authors trace that rewiring to a gene switch in a 2026 study. A lactate-born tag on histones runs high in resistant cells.
The tag sits on the promoter of a gene called HOXB13 and switches it on. That gene steadies a low-oxygen factor, which fires fat build-up paths. Blocking the tag or the gene melted the fat stores back. Treated cells also grew sensitive to the drug again. The chain hands drug makers three choke points to attack.
Catalog record
| CREATOR | Qingqing Xie, Fangxia Teng, Ting Ding, Huaizhe Zhang, Jian Huang, Shu Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |